Osteolytic lesion

DBCOND0020866Musculoskeletal and Connective Tissue DiseasesNutritional and Metabolic Diseases

Osteolytic lesion is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Classified under
Indicated drugs

Resolves to

Vocabularies
ICD-10M89.5SNOMED CT203510004MedDRA10031248UMLSC0302313

What you can answer from here — as of October 23, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Osteolytic lesion share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In